Agenovir's Acquisition

Agenovir was acquired by Vir Biotechnology on May 09, 2018.

Agenovir is a player in the research and development of a novel class of human therapeutics to address diseases associated with or caused by latent or persistent viral reservoirs. The individuals affe…

Articles about Agenovir's Acquisition: